413 related articles for article (PubMed ID: 30217217)
1. The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications.
Zheng H; Zhan Y; Liu S; Lu J; Luo J; Feng J; Fan S
J Exp Clin Cancer Res; 2018 Sep; 37(1):226. PubMed ID: 30217217
[TBL] [Abstract][Full Text] [Related]
2. Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.
Pan D; Chen J; Feng C; Wu W; Wang Y; Tong J; Zhou D
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646616
[TBL] [Abstract][Full Text] [Related]
3. Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer.
Liu S; Zhan Y; Luo J; Feng J; Lu J; Zheng H; Wen Q; Fan S
Biomed Pharmacother; 2019 Mar; 111():338-346. PubMed ID: 30590322
[TBL] [Abstract][Full Text] [Related]
4. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C
Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248
[TBL] [Abstract][Full Text] [Related]
5. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
[TBL] [Abstract][Full Text] [Related]
8. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
Clark DJ; Fondrie WE; Yang A; Mao L
J Proteomics; 2016 Feb; 133():161-169. PubMed ID: 26739763
[TBL] [Abstract][Full Text] [Related]
9. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
10. Small extracellular vesicles: Multi-functional aspects in non-small cell lung carcinoma.
Padinharayil H; George A
Crit Rev Oncol Hematol; 2024 Jun; 198():104341. PubMed ID: 38575042
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Song Z; Jia G; Ma P; Cang S
Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
[TBL] [Abstract][Full Text] [Related]
12. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
13. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
Whiteside TL
Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
[No Abstract] [Full Text] [Related]
14. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
[TBL] [Abstract][Full Text] [Related]
16. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis.
Yang Y; Kannisto E; Yu G; Reid ME; Patnaik SK; Wu Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43375-43386. PubMed ID: 30451486
[TBL] [Abstract][Full Text] [Related]
17. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
18. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
[TBL] [Abstract][Full Text] [Related]
20. Exosomes as potential sources of biomarkers in colorectal cancer.
Xiao Y; Zhong J; Zhong B; Huang J; Jiang L; Jiang Y; Yuan J; Sun J; Dai L; Yang C; Li Z; Wang J; Zhong T
Cancer Lett; 2020 Apr; 476():13-22. PubMed ID: 32044357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]